Allianz Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,200
| Closed | -$415K | – | 1999 |
|
|
2025
Q1 | $415K | Buy |
+6,200
| New | +$370K | ﹤0.01% | 1938 |
|
|
2024
Q3 | – | Sell |
-19,500
| Closed | -$1.24M | – | 2180 |
|
|
2024
Q2 | $1.24M | Buy |
19,500
+4,600
| +31% | +$299K | ﹤0.01% | 1504 |
|
|
2024
Q1 | $1.03M | Buy |
14,900
+3,300
| +28% | +$199K | ﹤0.01% | 1398 |
|
|
2023
Q4 | $640K | Buy |
11,600
+1,200
| +12% | +$66.1K | ﹤0.01% | 1769 |
|
|
2023
Q3 | $604K | Hold |
10,400
| – | – | ﹤0.01% | 1863 |
|
|
2023
Q2 | $560K | Buy |
+10,400
| New | +$461K | ﹤0.01% | 1703 |
|
|
2020
Q3 | – | Sell |
-11,897
| Closed | -$384K | – | 1875 |
|
|
2020
Q2 | $384K | Sell |
11,897
-22,756
| -66% | -$816K | ﹤0.01% | 2132 |
|
|
2020
Q1 | $1.41M | Buy |
34,653
+9,355
| +37% | +$498K | ﹤0.01% | 1653 |
|
|
2019
Q4 | $1.56M | Buy |
25,298
+436
| +2% | +$28.9K | ﹤0.01% | 1987 |
|
|
2019
Q3 | $1.81M | Sell |
24,862
-37,555
| -60% | -$2.81M | ﹤0.01% | 1868 |
|
|
2019
Q2 | $5.13M | Sell |
62,417
-681
| -1% | -$48.4K | ﹤0.01% | 1493 |
|
|
2019
Q1 | $4.45M | Sell |
63,098
-986
| -2% | -$58K | ﹤0.01% | 1521 |
|
|
2018
Q4 | $2.88M | Sell |
64,084
-3,120
| -5% | -$164K | ﹤0.01% | 1620 |
|
|
2018
Q3 | $3.8M | Sell |
67,204
-15,301
| -19% | -$936K | ﹤0.01% | 1684 |
|
|
2018
Q2 | $5.51M | Sell |
82,505
-1,566
| -2% | -$97.8K | 0.01% | 1482 |
|
|
2018
Q1 | $4.89M | Sell |
84,071
-9,460
| -10% | -$600K | ﹤0.01% | 1543 |
|
|
2017
Q4 | $6.03M | Sell |
93,531
-28,463
| -23% | -$1.77M | ﹤0.01% | 1545 |
|
|
2017
Q3 | $6.4M | Sell |
121,994
-25,744
| -17% | -$1.23M | 0.01% | 1504 |
|
|
2017
Q2 | $6.89M | Sell |
147,738
-10,206
| -6% | -$492K | 0.01% | 1464 |
|
|
2017
Q1 | $7.82M | Sell |
157,944
-20,281
| -11% | -$1.14M | 0.01% | 1439 |
|
|
2016
Q4 | $10.8M | Buy |
178,225
+12,202
| +7% | +$746K | 0.01% | 1324 |
|
|
2016
Q3 | $11M | Sell |
166,023
-31,867
| -16% | -$1.99M | 0.01% | 1283 |
|
|
2016
Q2 | $11M | Buy |
197,890
+12,151
| +7% | +$591K | 0.01% | 1186 |
|
|
2016
Q1 | $6.25M | Buy |
185,739
+2,910
| +2% | +$98.7K | 0.01% | 1363 |
|
|
2015
Q4 | $8.25M | Sell |
182,829
-33,312
| -15% | -$1.43M | 0.01% | 1143 |
|
|
2015
Q3 | $8.54M | Buy |
216,141
+2,579
| +1% | +$147K | 0.01% | 1052 |
|
|
2015
Q2 | $13.3M | Sell |
213,562
-3,162
| -1% | -$188K | 0.01% | 978 |
|
|
2015
Q1 | $13.6M | Sell |
216,724
-9,069
| -4% | -$552K | 0.02% | 840 |
|
|
2014
Q4 | $12.7M | Buy |
225,793
+222,593
| +6,956% | +$9.81M | 0.01% | 861 |
|
|
2014
Q3 | $90K | Hold |
3,200
| – | – | ﹤0.01% | 2259 |
|
|
2014
Q2 | $110K | Hold |
3,200
| – | – | ﹤0.01% | 1864 |
|
|
2014
Q1 | $100K | Buy |
+3,200
| New | +$84.9K | ﹤0.01% | 1852 |
|
Other funds holding ANIP
GACM
DTC
RIM
Allianz Asset Management's ANIP Position: Q2 2025 in Review
Allianz Asset Management sold out of ANI Pharmaceuticals (ANIP) in Q2 2025, closing a stake of 6,200 shares — an estimated $415K sold.
Allianz Asset Management first reported a position in ANIP in Q1 2014 and held it in 32 quarters. The position peaked at $13.6M in Q1 2015. 232 funds tracked by Wall St. Rank hold ANIP as of Q2 2025.
- Allianz Asset Management reported no remaining ANI Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
- Allianz Asset Management sold 6,200 ANI Pharmaceuticals shares in Q2 2025, an estimated $415K.
- Allianz Asset Management first reported a position in ANI Pharmaceuticals in Q1 2014 and held it in 32 quarters.
- Allianz Asset Management's ANI Pharmaceuticals position peaked at $13.6M in Q1 2015.
- 232 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2025.
Based on Allianz Asset Management's 13F filing for Q2 2025, filed 28 Jul 2025.